Compound ID | 190
Class: Antimicrobial peptide
| Agent Type: | Semisynthetic; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Membrane-active agent. Disrupts the outer membrane by direct interaction with the lipid A component of the LPS and disrupts the physical integrity of the phospholipid bilayer of the inner membrane |
| Description: | Semisynthetic compound derived from polymyxin B; exhibits less nephrotoxicity vs polymyxin B; potentiates and expands the activity to Gram-negative activity |
| Institute where first reported: | Northen Antibiotics, Finland |
| Year first mentioned: | 2008 |
| Highest development stage: | Preclinical |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/77282695 |
| Guide to Pharmacology: | NAB739 |
| Citations: |
|